News
35m
Money Talks News on MSN5.3 Million Medicare Users to Benefit From New Drug Price NegotiationsThe next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...
Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...
53m
MyHighPlains on MSNNew tariffs could raise prices of Ozempic, WegovySome of the most recognizable brand names that could be impacted by new tariffs include Ozempic and Wegovy, two injectable ...
Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...
GLP-1 drugs have become a focal point in the battle against obesity, a chronic condition affecting millions of Americans.
Novo Nordisk shares dropped as low as $46.90 in Thursday’s session, their lowest level since January 2022, following a profit warning.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results